Value Analysis and Payer Evidence

Hospitals and payers require clear, quantifiable evidence before adoption

Key Outcomes

A clear clinical and economic framework for value demonstration

Improved acceptance during hospital purchasing reviews

Reduced operational friction for early adopter sites

Faster and more predictable market access

Hospital value analysis committees and payer medical directors evaluate new technologies through structured clinical and economic criteria. Their goal is to confirm that the device improves outcomes, reduces resource use, or provides a justified incremental benefit. Without a strong value dossier, evidence plan, and payer aligned rationale, adoption slows and coverage decisions remain inconsistent.

Our team builds a complete value evidence foundation that supports hospital purchasing decisions and payer coverage determinations.

CHALLENGES

Common Evidence Gaps That Delay Adoption

Across early stage and international MedTech companies, several issues repeatedly limit hospital and payer acceptance

Clinical endpoints that do not reflect payer definitions of medical necessity

Insufficient comparator data or lack of relevance to U.S. standards of care

Absence of a structured health economic model to support cost savings or offset

Weak articulation of workflow benefits or operational efficiency improvements

Misalignment between FDA regulatory claims and payer coverage requirements

Missing documentation and coding support for hospital revenue cycle teams

These gaps lead to delays in value analysis reviews and challenge payer policy development

OUR PROCESS

How We Structure Value Analysis and Payer Evidence

UnifiMed integrates clinical, financial, and operational evidence into structured frameworks to meet value analysis and payer coverage expectations

Define Problems and Outcomes

We define the clinical condition, unmet need, target population, and expected impact, including safety considerations, workflow implications, staffing effects, and areas of potential resource utilization reduction

Evidence Requirements Alignment

We map the clinical, operational, and documentation evidence required by value analysis committees and payers, aligning endpoints, comparators, and performance metrics with medical necessity expectations

Financial & Budget Impact Modeling

We develop hospital- and payer-facing economic models that quantify cost offsets, projected case volumes, length-of-stay impact, and direct and indirect resource utilization changes

Value Dossier Development

We prepare a structured value dossier that integrates clinical value, economic rationale, workflow impact, comparator evidence, and coding, coverage, and payment alignment

Hospital Value Analysis Enablement

We support hospital-facing evaluation through value analysis guidance, purchasing committee materials, and documentation frameworks aligned with internal review processes

Payer Evidence and Coverage Support

We prepare payer-facing evidence packages, coverage documentation, and prior authorization support materials to enable consistent evaluation and informed coverage decision-making.

Ready to Learn More?

Contact our team to discuss how we can support your hospital value analysis and payer evidence